Cytokinetics’ bid to offer a new drug for amyotrophic lateral sclerosis (ALS) was dealt a setback after the company’s lead experimental treatment for the disease failed in a late-stage clinical trial.
The results mean the end for tirasemtiv, one of the... Read more »
We are only two weeks away from “What’s Hot in Cybersecurity”—and we’re offering you a chance to save $145 on regular registration. Join us for an afternoon of spotlight talks, fireside chats, and panel discussions that will delve into a... Read more »
As we head into holiday shopping season, here’s some news on the e-commerce warehouse front. Locus Robotics, based in Wilmington, MA, says it has secured $25 million in Series B funding led by Scale Venture Partners. The new money brings Locus... Read more »
[Updated, 2:45 pm ET, see below] Ed Kaye never thought he’d run a biotech —until waking up one day in 2015 realizing not only that he could, but that Sarepta Therapeutics, where he was chief medical officer at the... Read more »
Textbook publishers are making progress on shifting their businesses from print to mostly digital products. Now comes the hard part: figuring out how to reverse revenue declines when your business is built on digital course offerings that are generally much... Read more »
Like many tech entrepreneurs, Sean Behr had a young business that was popular with consumers, but was also losing money. So in February of 2016, he decided to refocus his San Francisco startup on the small, but unexpectedly profitable aspect of... Read more »
In our roundup this week, Alzheimer’s disease is in the news, thanks to billionaire Bill Gates and his personal pledge of $100 million toward R&D. That could equal the amount one startup hopes to raise in an IPO to develop drugs... Read more »
Our first forum focused on the intersection of healthcare and artificial intelligence was a truly standout event. We struck a nerve with this topic and timing, as healthcare and pharma companies are all trying to figure out (and implement) their A.I.... Read more »
The researchers and doctors at Seattle Children’s are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge CAR-T cell therapies, to help kids and young adults with an aggressive form of leukemia. As of today, one key part of... Read more »
Lessonly, the Indianapolis-based startup focused on team training software, this week announced it has raised an $8 million Series B funding round. Led by Boston’s OpenView Partners, the round also drew contributions from Rethink Education, High Alpha Capital... Read more »
When it comes to consumer robotics, iRobot has to be the poster child. It was born 27 years ago out of MIT, founded by legendary roboticist Rodney Brooks, now professor emeritus, and two of his students, Helen Greiner and Colin Angle.... Read more »
[Updated 11/16/17, 10:47 am. See below.] Dave Balter, a serial entrepreneur and startup investor in the Boston area, has stepped down as CEO of one of his latest ventures, Mylestone.
Balter has shifted to the role of chairman, and... Read more »
The immune system can’t fight disease if its cells don’t reach their targets. In some cancers and rare immune deficiency disorders, immune cell levels are too low. X4 Pharmaceuticals has developed drugs that it says can help restore these counts to... Read more »